Skip to contentC
Cardio Diagnostics Holdings, Inc.
C
CDIOCardio Diagnostics Holdings, Inc. Q3 2024 · 10-Q
Revenue$6.58K$6.58K−34.4% vs Q3 2023 Net Income-$1.41M-$1.41MN/M vs Q3 2023 EPS Diluted-$1.73-$1.73N/M vs Q3 2023 Operating Income-$1,408,967N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cardio Diagnostics Holdings, Inc. · CIK 1870144 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,180,605N/M Margins · derivedOperating margin-21412.9%−7014.2 pt vs Q3 2023
Net margin-21467.6%−2201.5 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 13, 2024 · 44 d after period end